Lack of Systemic Effects from Intra-articular XT-150 for the Treatment of Moderate to Severe Pain Due to OA of the Knee: Safety Results from a Phase 2 Trial

被引：0

作者：

Kapural, Leonard ^{[1
]}

Collins, Stephen D. ^{[2
]}

Grigsby, Eric ^{[3
]}

McBride, Mark

Rieger, Jayson ^{[4
]}

Stokes, Morgan ^{[5
]}

Rutman, Howard ^{[5
]}

Cicuttini, Flavia ^{[6
]}

机构：

[1] Ctr Clin Res, Salem, NC USA

[2] Xalud Therapeut Inc, Chicago, IL USA

[3] Neurovat Clin Res, Napa, CA USA

[4] PBM Capital, Charlottesville, VA USA

[5] Xalud Therapeut Inc, Berkeley, CA USA

[6] Monash Univ, Melbourne, Australia

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

INTERLEUKIN-10;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0314

引用

页码：612 / 614

页数：3

共 2 条

[1] The therapeutic potential of interleukin-10 in neuroimmune diseases [J].

Kwilasz, A. J. ;

Grace, P. M. ;

Serbedzija, P. ;

Maier, S. F. ;

Watkins, L. R. .

NEUROPHARMACOLOGY, 2015, 96 :55-69

[2] Targeted interleukin-10 plasmid DNA therapy in the treatment of osteoarthritis: Toxicology and pain efficacy assessments [J].

Watkins, Linda R. ;

Chavez, Raymond A. ;

Landry, Robert ;

Fry, Megan ;

Green-Fulgham, Suzanne M. ;

Coulson, Jonathan D. ;

Collins, Stephen D. ;

Glover, David K. ;

Rieger, Jayson ;

Forsayeth, John R. .

BRAIN BEHAVIOR AND IMMUNITY, 2020, 90 :155-166

← 1 →